3,6-disubstituted xanthylium salts and use thereof in treatment of tauopathies
US8658665B2 · kind B2 · utility
1Cited by
2References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 2009 |
| Grant date | Feb 25, 2014 |
| Priority date | — |
| Expiry date | Jan 12, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7047
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention pertains generally to processes, uses, methods and materials utilizing particular xanthylium compounds, including compounds of formula (I) and (II), as further defined herein. These compounds are useful as drugs, for example, in the treatment of tauopathies, such as Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.